AbX Biologics, Inc. — Form D
AbX Biologics, Inc. of CANTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-22. The offering totals $750K, of which $350K was reported sold. Industry: Other.
Offering
- Filed: 2019-07-22
- Form: D
- Accession: 0001783034-19-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $750K
- Amount sold: $350K
- Remaining: $400K
- Investors: 3
- Date of first sale: 2019-07-08
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-344776
Issuer
- Name: AbX Biologics, Inc.
- CIK: 0001783034
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 480 NEPONSET STREET, SUITE 10B, CANTON, MA, 02021
- Phone: 603-767-9155
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Garren Hilow | Director | Canton, MA |
| Garren Hilow | Executive Officer | Canton, MA |
Other filings by this issuer (1)
More